跳至主要内容
临床试验/CTRI/2026/02/103749
CTRI/2026/02/103749尚未招募不适用

Assessing the effectiveness of Homoeopathic medicines Aurum muriaticum natronatum and Fraxinus americana on regression of Intramural Fibroid A Comparative study

Dr Aaliyafatima Maldar1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2026年2月26日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
60
试验地点
1

研究概览

简要总结

Need for the study

Uterine fibroids are the most common benign growths of the uterus and are the most common benign solid tumors affecting women. They tend to be more prevalent in women who have never given birth (nulliparous) or those experiencing infertility with only one child. These fibroids are predominantly found in the uterine body, with distribution as follows: intramural (75%), subserosal (15%), and submucosal (5%).

A global age period cohort analysis conducted from 1990 to 2019 examined the burden of uterine fibroids, estimating around 9.64 million new cases and a total prevalence of approximately 226.05 million cases globally. In India, it affects approximately 37.65% of individuals in rural areas and about 24% in urban settings. Women in their reproductive years especially those in their 30’s and 40’s are at a higher risk of developing fibroids. Furthermore, research indicates that by the age of 50, nearly 70–80% of women may experience uterine fibroids.

Although the majority of fibroids (approximately 75%) do not present with symptoms, those that are symptomatic can lead to various clinical issues. Common symptoms include abnormal menstrual bleeding such as menorrhagia and metrorrhagia, as well as dysmenorrhea, dyspareunia, subfertility, pelvic pressure, recurrent miscarriages, lower abdominal and pelvic pain, and abdominal distension.

The chosen treatment approach should focus on promoting the regression of Intramural uterine fibroids. Research indicates that homeopathic remedies contribute to a reduction in the size of these fibroids.

Aurum muriaticum natronatum and Fraxinus americana are two such remedies considered in the treatment of uterine fibroid. According to Dr. Burnett, Aurum muriaticum natronatum demonstrates greater effectiveness in treating uterine tumors compared to other remedies. He also referred to Fraxinus americana as a uterine tonic, particularly useful in conditions involving an enlarged or heavy uterus, describing it as “the medicinal pessary”.

Hence, the study is intended to assess the effectiveness of Homoeopathic medicines Aurum muriaticum natronatum and Fraxinus americana on regression of Intramural uterine fibroid.

RESEARCH QUESTION: Is there any significant difference between the effectiveness of Homoeopathic medicines Aurum muriaticum natronatum and Fraxinus americana on regression of Intramural uterine fibroid?

NULL HYPOTHESIS (H0): There may not be a significant difference between the effectiveness of Homoeopathic medicines Aurum muriaticum natronatum and Fraxinus americana on regression of intramural uterine fibroid.

ALTERNATIVE HYPOTHESIS (H1): There may be a significant difference between the effectiveness of Homoeopathic medicines Aurum muriaticum natronatum and Fraxinus americana on regression of Intramural uterine fibroid.

研究设计

研究类型
Interventional
分配方式
Other
盲法
None

入排标准

年龄范围
25.00 Year(s) 至 45.00 Year(s)(—)
性别
Female

入选标准

  • Subjects who are willing to participate as volunteers in the study and sign the written informed consent.
  • Newly diagnosed cases of Intramural uterine fibroid.
  • Subjects between the age group of 25 to 45 years of age.
  • Intramural uterine fibroid of size up to 5cm.

排除标准

  • Pregnant and lactating mothers.
  • Subjects with Hypothyroidism, Hyperthyroidism, Gross developmental defect or congenital abnormalities of the uterus, Pelvic inflammatory diseases, Diabetes mellitus and Hypertension.
  • Fibroids with severe pain and bleeding with suspicion of acute torsion and other complications which needs immediate surgical intervention.
  • Subjects who are taking medication from other system of medicine and subjects taking Homoeopathic medicine for the same complaint.
  • Subjects with Hemoglobin less than 8g/dl.

研究者

发起方
Dr Aaliyafatima Maldar
申办方类型
Other [Principal investigator ]
责任方
Principal Investigator
主要研究者

Aaliyafatima Maldar

Government Homoepathic Medical College and Hospital

研究点 (1)

Loading locations...

相似试验